Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN107573333A reveals a mild trifluoroacetyl protection strategy for ticagrelor intermediates, enabling scalable production with reduced energy consumption and waste.
Patent CN106749259B reveals a metal-free synthetic route for CDK4/6 inhibitor intermediates, offering significant cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Novel ionic liquid catalysis method for high-purity pharmaceutical intermediates with reduced waste and simplified purification ensuring reliable supply chain efficiency.
Patent CN102702292B reveals solvent-free melt condensation for azacitidine. Enhances purity, reduces hydrolysis, and offers significant supply chain cost advantages.
Patent CN102264672A details a scalable route to chiral phenols using Ru-catalyzed transfer hydrogenation, offering cost reduction and high purity for pharmaceutical manufacturing.
Patent CN105732550B reveals Pd-catalyzed synthesis enabling high-purity chiral dihydrofuran intermediates with significant supply chain and cost advantages.
Patent CN1222537C reveals a novel Fmoc-strategy for Eptifibatide synthesis, eliminating toxic HF and reducing cycle time. Ideal for reliable peptide intermediate sourcing.
Patent CN104151283A reveals green ionic liquid catalysis for xanthene derivatives. Offers cost reduction in pharmaceutical intermediates manufacturing and scalable supply.
Patent CN1246308C reveals a mild acid-catalyzed route for beta-hydroxy sulfone derivatives. Discover cost-effective manufacturing and scalable supply chain solutions for high-purity intermediates.
Patent CN115613061A reveals a green electro-catalytic method for azide-substituted tetrazolo[1,5-a]indole synthesis, offering cost-effective scale-up for pharmaceutical intermediates.
Discover the biomass-derived synthesis of Benvitimod intermediates. This patent offers a green, scalable route with recyclable catalysts for cost-effective pharmaceutical manufacturing.
Patent CN111886235A reveals a continuous flow method for Trazodone. Achieve high purity, reduced toxicity, and scalable API intermediate manufacturing.
Patent CN111138325A reveals a safe, copper-catalyzed route to tetra-substituted Z-beta-sulfonyl enamines using solid SO2 sources, offering reliable pharmaceutical intermediate supply.
Patent CN106045804B enables aqueous asymmetric oxidation. Reduces solvent waste and improves catalyst recovery for pharmaceutical intermediates.
Patent CN116444503A details a rhodium-catalyzed route to chroman derivatives using pyridine triazoles, offering mild conditions and high purity for pharmaceutical manufacturing.
Patent CN115974758A reveals safe iridium-catalyzed synthesis avoiding diazo compounds. Delivers cost reduction in pharmaceutical intermediate manufacturing with superior scalability.
Novel 5-step route from o-nitrotoluene offers cost-effective production of high-purity o-aminophenylpropanol, avoiding high-pressure hydrogenation equipment.
Novel Grignard-based process for halofuginone intermediate offering superior yield and scalable production for veterinary pharmaceutical supply chains.
Patent CN102690273A details a robust six-step synthesis of Sildenafil featuring stable intermediates and high yields, offering significant cost reduction in pharmaceutical manufacturing.
Patent CN119638592A discloses a novel route for semaglutide side chain. Achieve high purity and reduced emulsification risks for scalable GLP-1 manufacturing.